Stock analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the ...

Local biotech Aardvark Therapeutics made its debut on the public market this month, making it San Diego’s first life science ...

The CAR T-cell therapy market size was valued at $2.6 billion in 2022 & is estimated to hit $35.9 billion by 2032, exhibiting a CAGR of 28 ...

The global non-opioid pain patches market is experiencing substantial growth, driven by increasing demand for safer and more effective pain management solutions. In 2022, the market surpassed USD 3.3 ...

The leading AL Amyloidosis Companies such as Caelum Biosciences, Nexcella, Inc., HaemaLogiX Ltd., Prothena, ZENTALIS ...

Counterfeit drugs are a $4 billion industry, with only 5% of online pharmacies accredited, posing significant risks. Younger patients are more susceptible to counterfeit drugs due to their familiarity ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Drug maker Trevi Therapeutics (TRVI) is climbing 4.5% after investment bank Stifel raised its price target on the name to $12 from $8. Stifel maintained a Buy rating on the shares. Why Stifel Is More ...

Drug maker Trevi Therapeutics (TRVI) is climbing 4.5% after investment bank Stifel raised its price target on the name to $12 from $8. Stifel maintained a Buy rating on the shares. Why Stifel Is ...

Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced the publication of ...